Clinical trial
Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent…
NCT00429572 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00429572 |
|---|---|
| Title | Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer |
| Official title | Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Fludarabine, Melphalan, Stem Cell Infusion |
| Enrollment | 19 |
| Start date | Jan 1, 1998 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jan 31, 2007 |
| Last update posted | Aug 7, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: